Stability of anticoagulant derivatives of 4-hydroxycoumarin. II. Structure of the principal degradation products of phenprocoumin, Clocoumarol, warfarin and acenocoumarin
Vanhaelen, M.; Vanhaelen-Fastré, R.
Pharmaceutica Acta Helvetiae 53(8): 221-230
1978
ISSN/ISBN: 0031-6865 PMID: 740707 Document Number: 134373
Document emailed within 1 workday
Related Documents
Amián, A.; Rodríguez, J.N.; Muñiz, R.; Diéguez, J.C.; Moreno, M.V.; Quesada, J.A.; Cañavate, M.; Fernández-Jurado, A.; Martino, M.L.; Prados, D. 1996: Comparative study of the stability of oral anticoagulant treatments (warfarin vs acenocoumarol) Sangre 41(1): 9-11Mehta, T.N.; Patel, A.K.; Kulkarni, G.M.; Suubbaiah, G. 2005: Determination of rosuvastatin in the presence of its degradation products by a stability-indicating LC method Journal - Association of Official Analytical Chemists 88(4): 1142-1147
Pfeifer, S.; Behnsen, G.; Kühn, L. 1972: Stability of alkaloids in organic solvents. 2. Degradation products of codeine, ethyl morphine, and thebaine Die Pharmazie 27(10): 648-650
Braun, K.; Kuhl, P.; Bernd, M.; Kutscher, B. 2001: Stability of several LHRH antagonists against proteolytic enzymes and identification of degradation products by mass spectrometry Die Pharmazie 56(1): 45-49
Döge, G.; Pohloudek-Fabini, R.; Kottke, D. 1982: Analysis and stability of suxamethonium chloride. 1. Detection and quantitative determination of the intact active agent with its degradation products Die Pharmazie 37(10): 708-711
Carroll, R.C.; Lockhart, M.S.; Taylor, F.B. 1984: Effect of crosslinking on the structure of solubilized fibrin degradation products in whole plasma Journal of Laboratory and Clinical Medicine 103(5): 695-703
Bourgain, R.H.; Vanden Driessche, R.; Smets, P. 1972: The anticoagulant activity of 3-1-phenyl-propyl-4-hydroxycoumarin in patients on "long-term" therapy Archives Internationales de Pharmacodynamie et de Therapie 195(2): 240-246
Kempa, H.; Brockelt, G.; Pohloudek-Fabini, R. 1970: Qualitative and quantitative detection of pethidine and its degradation products by means of thin layer chromatography. 1. Stability of injection solutions in polyethylene containers Die Pharmazie 25(5): 326-330
Mitcheva, M.; Vitcheva, V.; Manolov, I.; Valkova, I. 2002: Effects of two newly synthesized 4-hydroxycoumarin derivatives (4-OHC) on isolated rat hepatocytes Methods and Findings in Experimental and Clinical Pharmacology 24(6): 345-349
Li, W.-M.; Bao, Y.-Y.; Zhou, Q.-X. 2012: Degradation pathways and main degradation products of tetracycline antibiotics: research progress Ying Yong Sheng Tai Xue Bao 23(8): 2300-2308
Davis, L.J.; Kayser, S.R.; Hubsher, J.; Williams, R.L. 1984: Effect of oxaprozin on the steady-state anticoagulant activity of warfarin Clinical Pharmacy 3(3): 295-297
Levy, G.; O'Reilly, R.A.; Wingard, L.B. 1974: Relationship between the kinetics of the anticoagulant effects of racemic warfarin and its individual enantiomers in man Research Communications in Chemical Pathology and Pharmacology 7(2): 359-365
Kinzner, C.L. 1998: Warfarin sodium (Coumadin) anticoagulant Therapy for vascular access patency Anna Journal 25(2): 195-203; Quiz 204, 209
Yang, P.; Wu, Q.-H.; Luo, X.-Y.; Kou, L.; Chen, Z.; Zhang, Y.-Y.; Zhou, H. 2009: The study of Chinese optimal anticoagulant range of warfarin for venous thromboembolism Zhonghua Yi Xue Za Zhi 89(25): 1762-1765
Pattacini, C.; Manotti, C.; Pini, M.; Quintavalla, R.; Dettori, A.G. 1994: A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol) Thrombosis and Haemostasis 71(2): 188-191
Islam, M.S.; Islam, M.A.; Azad, A.K.; Banerjee, S.K.; Ahmed, C.M.; Haque, H.; Ahmed, M.K.; Rumki, R.S.; Mahmood, M.; Rashid, F.B. 2016: Use of Anticoagulant Warfarin in Patients Presenting with Atrial Fibrillation in a Tertiary Level Hospital Mymensingh Medical Journal: Mmj 25(3): 523-529
Olteanu, H.; Downes, K.A.; Patel, J.; Praprotnik, D.; Sarode, R. 2009: Warfarin Does Not Interfere with Lupus Anticoagulant Detection by Dilute Russell’s Viper Venom Time Clinical Laboratory 55(3-4): 138-142
Strain, J.; Templeton, K. 2013: Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation? South Dakota Medicine: the Journal of the South Dakota State Medical Association 66(1): 20-21
Marutaka, M.; Kubota, Y.; Yoshida, R.; Orita, Y. 2009: Difficult management of warfarin anticoagulant therapy due to S-1 administration for gastric cancer--report of a case Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1561-1563
Suwanawiboon, B.; Kongtim, P.; Chinthammitr, Y.; Ruchutrakool, T.; Wanachiwanawin, W. 2011: The efficacy of 3-mg warfarin initiating dose in adult Thai patients, who required long-term anticoagulant therapy Journal of the Medical Association of Thailand 94(Suppl 1): S225-S231